Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
8/18/2021
Novartis Secures New Chinese Approval for Cosentyx (Secukinumab) in Pe...
8/18/2021
NMPA Issues the List of Reference Formulations for GQCE Studies (44th ...
8/18/2021
CDE Solicits Comments on the Technical Guidance for Clinical Trial Pro...
8/18/2021
CDE Solicits Comments on the Technical Guidance for Clinical Trials of...
8/18/2021
CDE Solicits Comments on the Technical Guidance for Clinical Trials of...
8/18/2021
CDE Solicits Comments on the Technical Guidance for Adverse Drug React...
8/18/2021
Arthrosi Establishes JV in China to Accelerate Development of Innovati...
8/18/2021
Junshi and Coherus Announce U.S. FDA Breakthrough Therapy Designation ...
8/18/2021
China's New Biosecurity Law Gives Limited Insight into Government Prio...
8/17/2021
CDE Publicizes the List of Reference Formulations for GQCE Studies (48...
8/17/2021
Amgen Secures Chinese Approval of Its Psoriasis Drug Otezla (Apremilas...
8/17/2021
CDE Solicits Comments on Technical Guidance for Clinical Trials of New...
8/16/2021
IQVIA Provides Snapshot and Outlook of County Level Healthcare Market
8/16/2021
PharmCube Reviews Development Trends of First-in-Class Drugs in China
8/16/2021
Review of Pharmaceutical Distribution Industry Performance in 2020
8/16/2021
Novo Nordisk Launches Once-Weekly Ozempic (Semaglutide) Injection in ...
8/16/2021
BioShin's Chinese IND for New Glutamate Modulator Troriluzole Approve...
8/16/2021
Incyte and InnoCare Announce Collaboration and License Agreement for T...
8/16/2021
111, Inc. Deepens Partnership with Bayer Healthcare
8/16/2021
Gracell Biotech Signs Exclusive License Agreement with FutureGen to De...
8/16/2021
Arctic Vision and Clearside Expands ARVN001 License to Include ASEAN C...
8/16/2021
CDE Solicits Comments on the Technical Guidance for Research and Evalu...
8/16/2021
CDE Solicits Comments on Three Preclinical Guidance Documents for Covi...
8/16/2021
CDE Solicits Comments on Technical Guidance for Clinical Trials of Gen...
8/15/2021
PharmaDJ: China Strengthens Regulations for Clinical Use of Oncology D...
8/13/2021
China's Anti-Foreign Sanctions Law: How Businesses Should Prepare
8/13/2021
GC Pharma Announces GreenGene F Approval in China for the Treatment of...
8/12/2021
Sorrento to License Dyadic's Lead COVID-19 Vaccine Candidate and C1 Te...
8/12/2021
China Issues New Policy on Establishing the Medical Insurance Benefit ...
8/12/2021
NHC issues the Guidelines for Long Term Prescription Management (Inter...
Page:
118
/
719
Total number of articles:
21549
:
[First]
[<<]
[116]
[117]
[118]
[119]
[120]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit